Research map: Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy
Back to the article
Papers in this map
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge · William T. Friedewald · 1972 · 32636 citations · Cited by this paper
- Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use · 2026 · Related
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial · Writing Group for the Women's Health Initiative Investigators · 2002 · 15966 citations · Cited by this paper
- The Political Determinants of Obstetric Prescribing · 2026 · Related
- Diagnosis and Management of the Metabolic Syndrome · Scott M. Grundy · 2005 · 11930 citations · Cited by this paper
- Oral and Vaginal Probiotics and Pregnancy Outcomes in Women With Infertility · 2026 · Related
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women · Stephen B. Hulley · 1998 · 6283 citations · Cited by this paper
- Thyroid Function Throughout Pregnancy in Women With Subclinical Hypothyroidism or Hypothyroxinemia · 2026 · Related
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy · The Women's Health Initiative Steering Committee* · 2004 · 4510 citations · Cited by this paper
- The Role of Molecular Characterization in Precision Medicine in Endometriosis · 2026 · Related
- Design of the Women’s Health Initiative Clinical Trial and Observational Study · The Women’s Health Initiative Study Group · 1998 · 2617 citations · Cited by this paper
- The Legacy of One · 2026 · Related
- Estrogen plus Progestin and the Risk of Coronary Heart Disease · JoAnn E. Manson · 2003 · 2076 citations · Cited by this paper
- Evidence Is My Love Language · 2026 · Related
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials · JoAnn E. Manson · 2013 · 1647 citations · Cited by this paper
- A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth · 2026 · Related
- Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women · Sylvia W Wassertheil-Smoller · 2003 · 1163 citations · Cited by this paper
- The Effects of Climate Change on Obstetric and Gynecologic Health · 2026 · Related
- Observational Studies Analyzed Like Randomized Experiments · Miguel Ángel Hernán · 2008 · 826 citations · Cited by this paper
- Technological Advances in Fetal Surveillance: Long Overdue, More Work to Do: Correction · 2026 · Related
- Outcomes ascertainment and adjudication methods in the women's health initiative · J. David Curb · 2003 · 703 citations · Cited by this paper
- Multiple Imputation · Peng Li · 2015 · 655 citations · Cited by this paper
- Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality · JoAnn E. Manson · 2017 · 643 citations · Cited by this paper
- Estrogen Plus Progestin and Risk of Venous Thrombosis · Mary Cushman · 2004 · 639 citations · Cited by this paper
- Conjugated Equine Estrogens and Coronary Heart Disease · Judith A. Hsia · 2006 · 610 citations · Cited by this paper
- A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia · Maureen L. Sampson · 2020 · 585 citations · Cited by this paper
- Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population · Göran M.L. Bergström · 2021 · 445 citations · Cited by this paper
- Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative · Susan L. Hendrix · 2006 · 361 citations · Cited by this paper
- Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women · Satu Vehkavaara · 2001 · 271 citations · Cited by this paper
- Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women · Madge R. Vickers · 2007 · 256 citations · Cited by this paper
- Metalloproteinases and Vulnerable Atherosclerotic Plaques · Andrew C. Newby · 2007 · 253 citations · Cited by this paper
- Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus · J. David Curb · 2006 · 218 citations · Cited by this paper
- Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? · Leslie Cho · 2023 · 206 citations · Cited by this paper
- Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management · Diane R. Zanger · 2000 · 171 citations · Cited by this paper
- Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up · Karen P. Alexander · 2001 · 142 citations · Cited by this paper
- Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women · Hiroyuki Sumino · 2006 · 97 citations · Cited by this paper
- Risk of Recurrent Coronary Events in Relation to Use and Recent Initiation of Postmenopausal Hormone Therapy · Susan R. Heckbert · 2001 · 97 citations · Cited by this paper
- Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women's Health Initiative Trials of Hormone Therapy · Jacques E. Rossouw · 2008 · 86 citations · Cited by this paper
- Coronary heart disease events in the Women’s Health Initiative hormone trials · Robert A. Wild · 2012 · 72 citations · Cited by this paper
Source: OpenAlex (CC0)